Nascent Biotech Inc (OTCMKTS:NBIO)’s stock price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.14 and traded as low as $0.11. Nascent Biotech shares last traded at $0.11, with a volume of 180,460 shares.
The company’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.13.
About Nascent Biotech (OTCMKTS:NBIO)
Nascent Biotech, Inc, a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer.
Recommended Story: Should I follow buy, hold and sell recommendations?
Receive News & Ratings for Nascent Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nascent Biotech and related companies with MarketBeat.com's FREE daily email newsletter.